Literature DB >> 16757034

Validation of a mechanical apparatus for the measurement of avian walking.

Jonathan W Pinkston1, Marc N Branch.   

Abstract

Recent research has demonstrated that avian species may show an enhanced locomotor response to repeated drug exposure, a phenomenon called sensitization. Further research in this domain is warranted as such results not only establish the generality of previous findings, but may lend to a better understanding of sensitization in general. At present, there are no well-studied measurement devices for automating the measurement of bird movement. The present research evaluated a mechanical device comprised of moveable floor panels to assess its suitability. Evaluations of the device were made over the course of repeated cocaine administration. The results showed that there was high correspondence between the apparatus' responses and human observers' responses to movement by pigeons. The apparatus, furthermore, provided useful data on spatial orientation that revealed individual differences in the response to cocaine beyond those available from a collapsed measure of overall output. In sum, this recording strategy appears a viable instrument for the measurement of avian locomotion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757034     DOI: 10.1016/j.jneumeth.2005.12.023

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  3 in total

1.  Acute and chronic effects of cocaine on the spontaneous behavior of pigeons.

Authors:  Jonathan W Pinkston; Marc N Branch
Journal:  J Exp Anal Behav       Date:  2010-07       Impact factor: 2.468

2.  Development of key-pecking, pause, and ambulation during extended exposure to a fixed-interval schedule of reinforcement.

Authors:  Meredith S Berry; Brian D Kangas; Marc N Branch
Journal:  J Exp Anal Behav       Date:  2012-05       Impact factor: 2.468

3.  Limitations to the generality of cocaine locomotor sensitization.

Authors:  Julie A Marusich; Marc N Branch; Jesse Dallery
Journal:  Exp Clin Psychopharmacol       Date:  2008-08       Impact factor: 3.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.